Research of enalaprilat on neonatal rat cardiac fibroblasts proliferation and its mechanism;

Determination of enalapril and enalaprilat in human plasma by HPLC-MS;

Simultaneous determination of enalapril and its metabolite enalaprilat in human plasma by HPLC-MS and the study of their pharmacokinetics;

Research and market development of enalapril;

Effect of Enalapril on paroxysmal atrial fibrillation in patients with essential hypertension;

Clinical Effects of Enalapril Combined with Valsartan for Chronic Heart Failure;

Treatments of combined with medication of netrilix and enapril on heart failure induced by hypertensive heart disease;

The effect of Enapril on glomerular extracellular matrix accumulation in rats with 5/6 renal mass ablation;

Enapril 10 mg/d was taken by 38 subjects in control group, 40 subjects in treatment group were administered with enapril 10 mg/d and atorvastatin 20 mg/d orally.

Interventions of enalapril on mucus hypersecretion in rat airway epithelium.;

Determination of benazepril and benazeprilat in healthy human plasma by high-performance liquid chromatography;

A sensitive LC/MS/MS method was established to determine the plasma concentrations of benazepril and its active metabolite benazeprilat.

Objective: Benazepril and its active metabolite benazeprilat inhibit angiotensin-converting enzyme(ACE) and reduce the activity of ACE.